Tag: Cancer: Prostate
Many Can Avoid RT After Surgery for Localized Prostate Cancer
Progression-free survival no different at five years when radiotherapy is used only if the cancer returns
SBRT Shortens Tx for Prostate Cancer Without Greater Toxicity
Ultra-hypofractionated stereotactic body radiotherapy cuts treatment from two months to two weeks
Prostate Cancer Risk Higher in Men Receiving Fertility Treatment
Men who undergo assisted reproduction have higher risk for prostate cancer, early-onset disease
Comorbid CVD May Up Mortality With ADT for Prostate Cancer
Seniors with preexisting cardiovascular diseases have higher risk for short-term mortality with AA, ENZ
Adjuvant RT May Cut Recurrence in Some With Prostate Cancer
Adjuvant radiotherapy after surgery may prolong biochemical recurrence-free survival
Androgen Deprivation Therapy May Up Risk of Alzheimer Disease
ADT exposure linked to subsequent Alzheimer disease diagnosis among elderly men at eight years
Urine Biomarker Helps Classify Risk Level in Prostate Cancer
Urine-derived extracellular vesicle RNA provides diagnostic, prognostic information in prostate cancer
Combination Biopsy Strategy May Identify More Prostate Cancers
Lesion-targeted plus systematic sampling appears to maximize the accuracy of first-time prostate biopsy
Black Race Not Tied to Worse Prostate Cancer Mortality
Findings seen in cohorts of men with nonmetastatic disease after adjusting for nonbiological differences
Location of Body Fat Linked to Advanced, Fatal Prostate Cancer
Risk for advanced, fatal disease also increased in association with body mass index, waist circumference
